Loading…
Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation
Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation...
Saved in:
Published in: | Life sciences (1973) 2017-12, Vol.190, p.103-109 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3 |
container_end_page | 109 |
container_issue | |
container_start_page | 103 |
container_title | Life sciences (1973) |
container_volume | 190 |
creator | Kawada, Toru Shimizu, Shuji Yamamoto, Hiromi Miyamoto, Tadayoshi Shishido, Toshiaki Sugimachi, Masaru |
description | Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect.
In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1).
Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P |
doi_str_mv | 10.1016/j.lfs.2017.09.038 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1945719129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320517304885</els_id><sourcerecordid>1945719129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</originalsourceid><addsrcrecordid>eNp9kc-OFCEQxonRuOPqA3gxJF689AjdDQ3xZDbrn2QTPeiZ0FDtMumGFujJ7jv40NZkVg8ePJHi-9UHVR8hLznbc8bl28N-nsq-ZXzYM71nnXpEdlwNumGy44_JjrG2b7qWiQvyrJQDY0yIoXtKLlqlZa-42JFfXyGH9RaynekRctkKdRDrqYRpAldpmmg4XRwhJlSXdJdi8CECTZFmW6mzOdXgaQkR9RGrDNMMd80CPtgKqNwvq623UIOjNld8Ee3XDKVsGWiGH9tsa0jxOXky2bnAi4fzknz_cP3t6lNz8-Xj56v3N43r-6E2ox4cE62H3otx8D1IPUjLxMRG3_LODlIrrhV4xzrJnNUdFyO3AALU0DnfXZI3Z981p58blGqWUBzMs42AMxquezFwzVuN6Ot_0EPacsTfISWlElJxhRQ_Uy6nUnB8s-aw2HxvODOnqMzBYFTmFJVh2mBU2PPqwXkbcVN_O_5kg8C7MwC4imOAbIoLEB1uNWMwxqfwH_vfwoCoGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1966856818</pqid></control><display><type>article</type><title>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</title><source>ScienceDirect Journals</source><creator>Kawada, Toru ; Shimizu, Shuji ; Yamamoto, Hiromi ; Miyamoto, Tadayoshi ; Shishido, Toshiaki ; Sugimachi, Masaru</creator><creatorcontrib>Kawada, Toru ; Shimizu, Shuji ; Yamamoto, Hiromi ; Miyamoto, Tadayoshi ; Shishido, Toshiaki ; Sugimachi, Masaru</creatorcontrib><description>Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect.
In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1).
Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P<0.05) without changing the minimum AP (77.2±6.4 to 80.7±5.1mmHg, not significant). In the neural arc, moxonidine reduced the minimum SNA (56.6±5.9 to 29.7±6.2%, P<0.05) without affecting the range of the SNA response (45.3±5.5 to 40.2±5.0%, not significant). In the peripheral arc, moxonidine increased the intercept (3.0±8.5 to 51.1±7.2mmHg, P<0.01) and reduced the slope (1.28±0.06 to 0.92±0.15mmHg/%, P<0.05).
Moxonidine increased AP at any given SNA, suggesting that the peripheral vasoconstrictive effect is stronger than generally recognized. The peripheral vasoconstrictive effect of moxonidine may partly offset the vasodilatory effect attained by centrally-mediated sympathoinhibition.
[Display omitted]</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2017.09.038</identifier><identifier>PMID: 28964815</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adrenergic receptors ; Animals ; Antihypertensive Agents - pharmacology ; Antihypertensives ; Arterial Pressure - drug effects ; Baroreceptors ; Baroreflex - drug effects ; Blood pressure ; Carotid sinus ; Carotid Sinus - drug effects ; Carotid Sinus - metabolism ; Carotid sinus baroreflex ; Clinical trials ; Drug delivery systems ; Drugs ; Imidazoles - administration & dosage ; Imidazoles - pharmacology ; Imidazoline ; Imidazoline agonist ; Imidazoline receptors ; Infusions, Intravenous ; Injections, Intravenous ; Intravenous administration ; Male ; Mercury ; Moxonidine ; Open-loop systems analysis ; Rats ; Rats, Wistar ; Receptors ; Receptors (physiology) ; Reflexes ; Rodents ; Selectivity ; Sinus ; Sympathetic nerve activity ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - metabolism ; Vasoconstriction - drug effects</subject><ispartof>Life sciences (1973), 2017-12, Vol.190, p.103-109</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier BV Dec 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</citedby><cites>FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</cites><orcidid>0000-0002-4429-1802</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28964815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawada, Toru</creatorcontrib><creatorcontrib>Shimizu, Shuji</creatorcontrib><creatorcontrib>Yamamoto, Hiromi</creatorcontrib><creatorcontrib>Miyamoto, Tadayoshi</creatorcontrib><creatorcontrib>Shishido, Toshiaki</creatorcontrib><creatorcontrib>Sugimachi, Masaru</creatorcontrib><title>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect.
In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1).
Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P<0.05) without changing the minimum AP (77.2±6.4 to 80.7±5.1mmHg, not significant). In the neural arc, moxonidine reduced the minimum SNA (56.6±5.9 to 29.7±6.2%, P<0.05) without affecting the range of the SNA response (45.3±5.5 to 40.2±5.0%, not significant). In the peripheral arc, moxonidine increased the intercept (3.0±8.5 to 51.1±7.2mmHg, P<0.01) and reduced the slope (1.28±0.06 to 0.92±0.15mmHg/%, P<0.05).
Moxonidine increased AP at any given SNA, suggesting that the peripheral vasoconstrictive effect is stronger than generally recognized. The peripheral vasoconstrictive effect of moxonidine may partly offset the vasodilatory effect attained by centrally-mediated sympathoinhibition.
[Display omitted]</description><subject>Adrenergic receptors</subject><subject>Animals</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Antihypertensives</subject><subject>Arterial Pressure - drug effects</subject><subject>Baroreceptors</subject><subject>Baroreflex - drug effects</subject><subject>Blood pressure</subject><subject>Carotid sinus</subject><subject>Carotid Sinus - drug effects</subject><subject>Carotid Sinus - metabolism</subject><subject>Carotid sinus baroreflex</subject><subject>Clinical trials</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Imidazoles - administration & dosage</subject><subject>Imidazoles - pharmacology</subject><subject>Imidazoline</subject><subject>Imidazoline agonist</subject><subject>Imidazoline receptors</subject><subject>Infusions, Intravenous</subject><subject>Injections, Intravenous</subject><subject>Intravenous administration</subject><subject>Male</subject><subject>Mercury</subject><subject>Moxonidine</subject><subject>Open-loop systems analysis</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors</subject><subject>Receptors (physiology)</subject><subject>Reflexes</subject><subject>Rodents</subject><subject>Selectivity</subject><subject>Sinus</subject><subject>Sympathetic nerve activity</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - metabolism</subject><subject>Vasoconstriction - drug effects</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc-OFCEQxonRuOPqA3gxJF689AjdDQ3xZDbrn2QTPeiZ0FDtMumGFujJ7jv40NZkVg8ePJHi-9UHVR8hLznbc8bl28N-nsq-ZXzYM71nnXpEdlwNumGy44_JjrG2b7qWiQvyrJQDY0yIoXtKLlqlZa-42JFfXyGH9RaynekRctkKdRDrqYRpAldpmmg4XRwhJlSXdJdi8CECTZFmW6mzOdXgaQkR9RGrDNMMd80CPtgKqNwvq623UIOjNld8Ee3XDKVsGWiGH9tsa0jxOXky2bnAi4fzknz_cP3t6lNz8-Xj56v3N43r-6E2ox4cE62H3otx8D1IPUjLxMRG3_LODlIrrhV4xzrJnNUdFyO3AALU0DnfXZI3Z981p58blGqWUBzMs42AMxquezFwzVuN6Ot_0EPacsTfISWlElJxhRQ_Uy6nUnB8s-aw2HxvODOnqMzBYFTmFJVh2mBU2PPqwXkbcVN_O_5kg8C7MwC4imOAbIoLEB1uNWMwxqfwH_vfwoCoGw</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Kawada, Toru</creator><creator>Shimizu, Shuji</creator><creator>Yamamoto, Hiromi</creator><creator>Miyamoto, Tadayoshi</creator><creator>Shishido, Toshiaki</creator><creator>Sugimachi, Masaru</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4429-1802</orcidid></search><sort><creationdate>20171201</creationdate><title>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</title><author>Kawada, Toru ; Shimizu, Shuji ; Yamamoto, Hiromi ; Miyamoto, Tadayoshi ; Shishido, Toshiaki ; Sugimachi, Masaru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adrenergic receptors</topic><topic>Animals</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Antihypertensives</topic><topic>Arterial Pressure - drug effects</topic><topic>Baroreceptors</topic><topic>Baroreflex - drug effects</topic><topic>Blood pressure</topic><topic>Carotid sinus</topic><topic>Carotid Sinus - drug effects</topic><topic>Carotid Sinus - metabolism</topic><topic>Carotid sinus baroreflex</topic><topic>Clinical trials</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Imidazoles - administration & dosage</topic><topic>Imidazoles - pharmacology</topic><topic>Imidazoline</topic><topic>Imidazoline agonist</topic><topic>Imidazoline receptors</topic><topic>Infusions, Intravenous</topic><topic>Injections, Intravenous</topic><topic>Intravenous administration</topic><topic>Male</topic><topic>Mercury</topic><topic>Moxonidine</topic><topic>Open-loop systems analysis</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors</topic><topic>Receptors (physiology)</topic><topic>Reflexes</topic><topic>Rodents</topic><topic>Selectivity</topic><topic>Sinus</topic><topic>Sympathetic nerve activity</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - metabolism</topic><topic>Vasoconstriction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawada, Toru</creatorcontrib><creatorcontrib>Shimizu, Shuji</creatorcontrib><creatorcontrib>Yamamoto, Hiromi</creatorcontrib><creatorcontrib>Miyamoto, Tadayoshi</creatorcontrib><creatorcontrib>Shishido, Toshiaki</creatorcontrib><creatorcontrib>Sugimachi, Masaru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawada, Toru</au><au>Shimizu, Shuji</au><au>Yamamoto, Hiromi</au><au>Miyamoto, Tadayoshi</au><au>Shishido, Toshiaki</au><au>Sugimachi, Masaru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>190</volume><spage>103</spage><epage>109</epage><pages>103-109</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Moxonidine is a centrally acting antihypertensive agent with a selectivity to I1-imidazoline receptors higher than that to α2-adrenergic receptors. The present study aimed to quantify a peripheral effect of moxonidine on carotid sinus baroreflex-mediated sympathetic arterial pressure (AP) regulation separately from its central effect.
In eight anesthetized Wistar rats, changes in efferent sympathetic nerve activity (SNA) and AP in response to a carotid sinus pressure input were compared before and during an intravenous administration of moxonidine (100μgkg−1 bolus followed by a continuous infusion at 200μg·kg−1·h−1).
Moxonidine significantly narrowed the range of the AP response (55.3±5.8 to 39.1±6.1mmHg, P<0.05) without changing the minimum AP (77.2±6.4 to 80.7±5.1mmHg, not significant). In the neural arc, moxonidine reduced the minimum SNA (56.6±5.9 to 29.7±6.2%, P<0.05) without affecting the range of the SNA response (45.3±5.5 to 40.2±5.0%, not significant). In the peripheral arc, moxonidine increased the intercept (3.0±8.5 to 51.1±7.2mmHg, P<0.01) and reduced the slope (1.28±0.06 to 0.92±0.15mmHg/%, P<0.05).
Moxonidine increased AP at any given SNA, suggesting that the peripheral vasoconstrictive effect is stronger than generally recognized. The peripheral vasoconstrictive effect of moxonidine may partly offset the vasodilatory effect attained by centrally-mediated sympathoinhibition.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>28964815</pmid><doi>10.1016/j.lfs.2017.09.038</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-4429-1802</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0024-3205 |
ispartof | Life sciences (1973), 2017-12, Vol.190, p.103-109 |
issn | 0024-3205 1879-0631 |
language | eng |
recordid | cdi_proquest_miscellaneous_1945719129 |
source | ScienceDirect Journals |
subjects | Adrenergic receptors Animals Antihypertensive Agents - pharmacology Antihypertensives Arterial Pressure - drug effects Baroreceptors Baroreflex - drug effects Blood pressure Carotid sinus Carotid Sinus - drug effects Carotid Sinus - metabolism Carotid sinus baroreflex Clinical trials Drug delivery systems Drugs Imidazoles - administration & dosage Imidazoles - pharmacology Imidazoline Imidazoline agonist Imidazoline receptors Infusions, Intravenous Injections, Intravenous Intravenous administration Male Mercury Moxonidine Open-loop systems analysis Rats Rats, Wistar Receptors Receptors (physiology) Reflexes Rodents Selectivity Sinus Sympathetic nerve activity Sympathetic Nervous System - drug effects Sympathetic Nervous System - metabolism Vasoconstriction - drug effects |
title | Peripheral versus central effect of intravenous moxonidine on rat carotid sinus baroreflex-mediated sympathetic arterial pressure regulation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A35%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peripheral%20versus%20central%20effect%20of%20intravenous%20moxonidine%20on%20rat%20carotid%20sinus%20baroreflex-mediated%20sympathetic%20arterial%20pressure%20regulation&rft.jtitle=Life%20sciences%20(1973)&rft.au=Kawada,%20Toru&rft.date=2017-12-01&rft.volume=190&rft.spage=103&rft.epage=109&rft.pages=103-109&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2017.09.038&rft_dat=%3Cproquest_cross%3E1945719129%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-b97c052de4d5b7d4e6976a05f0bd213a7698198edc0360ca9315b1aee5e873cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1966856818&rft_id=info:pmid/28964815&rfr_iscdi=true |